VRAYQ — Viewray Share News
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
- $0.00m
- -$3.53m
- $102.21m
Brief: ViewRay Announces China Nmpa Approval Of Its Mridian® Mri-Guided Radiation Therapy For Cancer Patients
Brief: Va Houston Healthcare System Selects Viewray To Expand Advanced Radiation Therapy Services
Brief: Viewray Q2 Loss Per Share $0.15
ViewRay Inc expected to post a loss of 15 cents a share - Earnings Preview
ViewRay Inc reports results for the quarter ended in March - Earnings Summary
Brief: Viewray Announces First Quarter 2022 Results
ViewRay Inc expected to post a loss of 16 cents a share - Earnings Preview
ViewRay Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Viewray Inc Says On April 4, Co Entered Into An Agreement By And Among Viewray, Viewray Technologies Inc And Siemens, Healthcare GmbH
Brief: First Toxicity Results From Scimitar Prospective Phase Ii Trial Signal Favorable Toxicity Profile Of Post-Prostatectomy Stereotactic Body Radiotherapy (SBRT) For Prostate Cancer
Brief: Viewray Enters Into Cooperation Agreement With Hudson Executive Capital
Brief: Viewray Announces Fourth Quarter And Full Year 2021 Results
ViewRay Inc reports results for the quarter ended in December - Earnings Summary
ViewRay Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Interim Findings From Mirage Phase III Randomized Trial Signal Superiority Of Mridian Mri-Guidance In Stereotactic Body Radiotherapy
Brief: Viewray Inc - Preliminary Unaudited Total Revenue For The Q4 2021 Was Approximately $20 Million
Brief: ViewRay Receives 510(K) Clearance On Next Generation Of Mridian Mri-Guided Radiation Therapy Features
U.S. STOCKS ON THE MOVE-Baidu, Rockwell Medical, Star Bulk Carriers
ViewRay down after pricing $70 mln equity offering